Altimmune Management - Simply Wall St

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available. *example for US securities, for non-US equivalent regulatory forms and sources … See more

CouponFollow Extension

56%
OFF

With 56% Institutional Ownership, Altimmune, Inc. (NASDAQ:ALT) …

2 weeks from now

3 days ago · [email protected] (Simply Wall St) Tue, Feb 4, 2025, 5:10 AM 4 min read. In This Article: ALT . Key Insights. ... Altimmune already has institutions on the share …

yahoo.com

$649
OFF

Here's Why Altimmune, Inc.'s (NASDAQ:ALT) CEO Compensation Is …

2 weeks from now

Sep 17, 2021 · Our data indicates that Altimmune, Inc. has a market capitalization of US$649m, and total annual CEO compensation was reported as US$1.4m for the year to December …

nasdaq.com

68%
OFF

With 68% Institutional Ownership, Altimmune, Inc. (NASDAQ:ALT) …

2 weeks from now

Aug 6, 2023 · Key Insights. Given the large stake in the stock by institutions, Altimmune's stock price might be vulnerable to their trading decisions. The top 15 shareholders own 51% of the …

yahoo.com

56%
OFF

With 56% Ownership, Altimmune, Inc. (NASDAQ:ALT) Boasts Of …

2 weeks from now

Aug 1, 2024 · With 56% ownership, Altimmune, Inc. (NASDAQ:ALT) boasts of strong institutional backing [email protected] (Simply Wall St) Thu, Aug 1, 2024, 8:47 AM 4 min read

yahoo.com

14%
OFF

Why Altimmune Was Such A Robustly Healthy Stock On Thursday

2 weeks from now

Dec 19, 2024 · Altimmune (ALT-5.14%) had some encouraging news to share with the world as the trading week drew near a close on Thursday. The biotech announced that it will soon …

fool.com

$182
OFF

Does Altimmune Have A Long Cash Runway? - Yahoo Finance

2 weeks from now

Jun 21, 2024 · When Altimmune last reported its March 2024 balance sheet in May 2024, it had zero debt and cash worth US$182m. Importantly, its cash burn was US$73m over the trailing …

yahoo.com

59%
OFF

Institutional Investors Control 59% Of Altimmune, Inc ... - Simply …

2 weeks from now

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. …

simplywall.st

FAQs about Altimmune Management - Simply Wall St Coupon?

Is altimmune a good investment?

Altimmune already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. ...

Is altimmune a good stock to buy?

Altimmune already has institutions on the share registry. Indeed, they own a respectable stake in the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. ...

Does altimmune need more cash?

While its cash burn is only increasing slightly, Altimmune shareholders should still consider the potential need for further cash, down the track. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. ...

Does altimmune have a cash runway?

A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at June 2022, Altimmune had cash of US$185m and no debt. Importantly, its cash burn was US$70m over the trailing twelve months. That means it had a cash runway of about 2.6 years as of June 2022. ...

Why should institutional investors invest in altimmune?

Since institutional have access to huge amounts of capital, their market moves tend to receive a lot of scrutiny by retail or individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. In the chart below, we zoom in on the different ownership groups of Altimmune. ...

Who owns altimmune stock?

Altimmune is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is BlackRock, Inc. with 5.7% of shares outstanding. For context, the second largest shareholder holds about 5.5% of the shares outstanding, followed by an ownership of 4.4% by the third-largest shareholder. ...